Joel Habener, a professor at Harvard Medical School, was awarded the 2024 Lasker~DeBakey Clinical Medical Research Award for his discovery of glucagon-like peptide-1 (GLP-1), a hormone that has become the basis for therapies transforming the treatment of obesity and type 2 diabetes. This market resolves to 'Yes' if Joel Habener is awarded the Nobel Prize in Physiology or Medicine before January 1, 2030, specifically for his work on GLP-1. Resolution will be based on official announcements from the Nobel Prize organization.